World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
28333
World Ranking
12714
National Ranking
1196

Overview

Kimme L. Hyrich is affiliated with the University of Manchester in the United Kingdom and has a focused research profile in the field of medicine, particularly within rheumatology.

Their research covers several main fields and subfields including:

  • Medicine
  • Rheumatology
  • Hematology
  • Immunology
  • Infectious Diseases
  • Speech and Hearing

Key topics addressed in their work involve:

  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Systemic Lupus Erythematosus Research
  • Adolescent and Pediatric Healthcare
  • Chronic Lymphocytic Leukemia Research
  • COVID-19 Clinical Research Studies
  • Biosimilars and Bioanalytical Methods

Kimme L. Hyrich has an extensive publication record in multiple venues, with notable frequent venues including:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Rheumatology Advances in Practice
  • Arthritis & Rheumatology
  • The Lancet Rheumatology

Selected recent papers authored by Kimme L. Hyrich show the breadth of research focus and include:

  • "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update" (2022), published in Annals of the Rheumatic Diseases
  • "Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry" (2020), published in Annals of the Rheumatic Diseases
  • "Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry" (2021), published in Annals of the Rheumatic Diseases
  • "EULAR definition of difficult-to-treat rheumatoid arthritis" (2020), published in Annals of the Rheumatic Diseases
  • "Juvenile idiopathic arthritis" (2022), published in Nature Reviews Disease Primers

The scientist collaborates regularly with several frequent co-authors, including:

  • Lianne Kearsley-Fleet
  • Anne Barton
  • Anja Strangfeld
  • Saskia Lawson-Tovey
  • Pedro Machado

Best Publications

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Milena Gianfrancesco;Kimme L Hyrich;Sarah Al-Adely;Loreto Carmona

  • Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

    W. G. Dixon;K. Watson;M. Lunt;K. L. Hyrich

  • Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

    Kimme L. Hyrich;Kath D. Watson;Alan J. Silman;Deborah P. M. Symmons

  • Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

    W. G. Dixon;K. L. Hyrich;K. D. Watson;M. Lunt

  • Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

    James B. Galloway;Kimme L. Hyrich;Louise K. Mercer;William G. Dixon

  • Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

    W. G. Dixon;K. D. Watson;M. Lunt;K. L. Hyrich

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.

    Kimme L. Hyrich;Mark Lunt;Kath D. Watson;Deborah P. M. Symmons

  • EULAR definition of difficult-to-treat rheumatoid arthritis

    György Nagy;Nadia Mt Roodenrijs;Paco Mj Welsing;Melinda Kedves

  • Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

    W. G. Dixon;D. P. M. Symmons;M. Lunt;K. D. Watson

  • Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

    C Potter;K L Hyrich;A Tracey;M Lunt

  • Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

    Mark J Harrison;William G Dixon;Kath D Watson;Yvonne King

  • Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

    W G G Dixon;K L L Hyrich;K D D Watson;M Lunt

  • Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

    W G Dixon;K D Watson;M Lunt;L K Mercer

  • BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

    Tina Ding;Jo Ledingham;Raashid Luqmani;Sarah Westlake

  • Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

    Rebeccah J Mathews;James I Robinson;James I Robinson;Michele Battellino;Chi Wong;Chi Wong

  • A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

    Jeffrey R. Curtis;Archana Jain;Johan Askling;S. Louis Bridges

  • Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

    Suzanne M M Verstappen;Yvonne King;Kath D Watson;Deborah P M Symmons

  • Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

    Elena Nikiphorou;Helga Radner;Katerina Chatzidionysiou;Katerina Chatzidionysiou;Carole Desthieux

  • Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register.

    Amr A Saad;Darren M Ashcroft;Kath D Watson;Kimme L Hyrich

Frequent Co-Authors

Deborah P. M. Symmons
Deborah P. M. Symmons University of Manchester
Mark Lunt
Mark Lunt University of Manchester
Wendy Thomson
Wendy Thomson University of Manchester
Anne Barton
Anne Barton University of Manchester
John D. Isaacs
John D. Isaacs Newcastle University
Ann W. Morgan
Ann W. Morgan University of Leeds
Lucy R. Wedderburn
Lucy R. Wedderburn University College London
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Johan Askling
Johan Askling Karolinska Institute
Ian N. Bruce
Ian N. Bruce University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medicine, various online degrees offer flexible and affordable entry points. Nursing remains a popular pathway. If you’re a registered nurse looking to advance your credentials affordably, explore the cheapest online rn to bsn programs for options that fit your budget.

Individuals with a non-nursing background can transition into advanced nursing roles through direct entry msn programs for non-nurses online, which are designed for those seeking faster routes to a Master’s in Nursing.

If you’re just starting out and seeking accessible programs, consider nursing schools with high acceptance rates. These schools often provide more flexible admission criteria, making them a practical choice for many aspiring nurses.

For those interested in the administrative side of healthcare, check out medical billing and coding online schools that accept financial aid. This field offers remote and entry-level opportunities without the need for extensive clinical training.

Best Scientists Citing Kimme L. Hyrich

Trending Scientists

Recently Published Articles